Creo Medical Group PLC is discussed by Proactive research analyst Daniel Appiah who talks Thomas Warner through his latest report.
Two licensing revenue deals this year will see Creo’s technology used in robotics-assisted laparoscopic (keyhole) surgery to enhance the effectiveness of procedures.
Creo’s technology allows minimally invasive endoscopic technology and licensing can be a very important revenue stream in future, Appiah adds.
#proactiveinvestors #creomedical
source